Disclosure of Faculties Industry Relationships

Faculty Disclosure
The Heart Rhythm Society maintains a Code of Ethics and Professional Standards and an Ethics Committee that oversees disclosure and conflict of interest policies to safeguard the credibililty and reputation of the Society.

It is the policy of the Heart Rhythm Society to uphold the highest ethical values and to encourage professional and principled behavior by our volunteers, faculty participants, and staff.  The Code is binding on all volunteers, faculty participants, and staff. It requires you to avoid conflicts between your personal, professional, or business interests and the interests of the Society.

Heart Rhythm Society requires faculty and other individuals who are in a position to control the content of CME activities to disclose any real or apparent conflict of interest they may have as related to the content of the activity. All identified conflicts of interest are thoroughly vetted by HRS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Heart Rhythm Society is committed to the provision of CME that is balanced, objective, and evidence based. In accordance with Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, Heart Rhythm Society requires that faculty participating in CME activities disclose to the audience any significant relationship they may have with a pharmaceutical or medical equipment company or service that may be mentioned as part of their presentation, as well as any relationship with the commercial support of this activity.

 

Category  Description
Consulting Fees/Honoraria including honoraria from a third party, gifts or in-kind compensation for consulting, lecturing, travel, advisory board service, legal testimony or consultation, or other purpose

Speaker’s Bureau

A. Equity Interests/Stock Options (or entitlement to the same), including a non-publicly traded company

B. Equity Interests (or entitlement to the same) in a publicly traded and financially related company

C. Royalty Income or the right to receive future royalties under a license or copyright, where the topic is     directly related to the licensed technology or work under discussion

D. Non-Royalty Payments or entitlements to payments in connection with the activity that are not directly related to the reasonable costs of that activity

E. Officer, Trustee, Director, or Any Other Fiduciary Role whether or not remuneration is received for service

F. Ownership/Partnership/Principal excluding mutual diversified funds

G. Research Grants from a financially interested company

H. Fellowship Support

I. Salary or position funding (partial or full) or “in-kind” support of program

J. Intellectual Property Rights including patent or other intellectual property in a for-profit corporation

K. Other financial benefit (please specify)

 

Off-Label/Unapproved Use Disclosure
Heart Rhythm Society requires that all authors identify and disclose any “off-label”/”unapproved” uses for pharmaceutical and medical device products.